Potential, page-27

Hi all. I'm a quiet reader/trader who was introduced to ePAT through a colleague last week. Sounds like the company is going to have an exiting 8 months or so. It's quite obvious that smart money is starting to accumulate and there's a lot of 'positives' out there at the moment so well done to those who got in below 3c. This kind of hype/action reminds me of RAP in its early days 12+ months ago. I don't usually comment on threads, but i've been doing some DD and i'm curious to know if any analysts out there have done/shared any calcs, examples or predictions on what the potential market cap + SP could be once FDA approval + first commercial sales start coming in for ePAT around Q4 2017/Q1 2018 – like they're expecting? Looking forward to hearing any banter. Cheers.